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I. INTRODUCTION 
If drugs are to be applied toward the solution 
of a problem, there must be some way of testing such 
drugs. The sounder the test, the more reliable are the 
results obtained, and the more fruitful the search. 
Ia a sense, research fellows a dialectic pattern: 
Do sooner is a thesis proposed, t.ltan it encounters aa 
aDtithesis; when the smoke clears, we are enabled to 
arrive at a synthesis, which in turn is destined to 
re-enter the cycle as a new thesis. 
Since Bigelow (6) first suggested t.he application 
of aypotheraia as an adjumct to cardiac surgery, many of 
the factors influenciag the incidence of ventricular 
fibrillation (VF) such as pH changes (9, 13, 21), choice 
of anesthetic agent (4, 24), mechanical irritants (17), 
etc., have been investigated, and clarified. The elucid-
ation of these factors has provided a sounder basis for 
the interpretation of effects observed (10, 11, 3) with 
antifibrillary (AF) erugs. 
The task here is to analyze amd integrate the inform-
aion derived from previeus methods; to combine their 
desirable features, and to minimize their shortcomings, 
man effort to develop a mGre reliable way of evalu-
ating AF agents. 
1. 
II. REVIEW OF PERTINENT BACKGROUND 
1. Ventricular Fibrillation 
One of the foremost problems encountered in hypothermia 
is the increased susceptibility of the myocardium to VF., 
both in the human (5) and in its experimental proxy, 
the dog (6). 
VP is a state in which the orderly, coordinated and 
useful contractions of the ventricles are replaced by the 
supervention of irregular, disorderly, uncoordinated and 
useless contractions. Since cardiac output is virtually 
nil when the ventricles are fibrillating, the persistence 
of such a state is not compatible with life. Interest in 
this phenomenon is not new. 
Based on the 1908 experiments of Mayer on the 
jellyfish Garrey and Mines in 1914 advanced the circus 
movement theory as a possible underlying factor of VF 
(14, 19). Their work was furthered by Lewis in 1925 
(18), who postulated that circus movements tend to be 
perpetuated by slowed conduction, shortened refractory 
period, and lengthened path of conduction; whereas the 
converse of these factors would tend to eliminate the 
circus movement. 
Brooks (7) states that certain conditions predispose 
to VF: 
1. "An acceleration of the heart rate beyond 
1. 
the ability of all the elements to 
follow, can disorganize the heart and 
cause fibrillation." 
2. "A localized exci tati on" can lead to 
a disorganized sequence ef events endiag 
in VF. 
3. Beth sborteniag ana lengthening of the 
refractery period can result in VF. 
Prinzmetal (22) on the basis of high speea cinemato-
graphic studies has refuted the evidence for circus move-
meats in VF; he proposed that "fibrillation originates from 
and is perpetuated by a single, rapidly discharging ectopic 
focus" (23). 
Wiggers, Wegria, Moe, Harris, et al, have studied 
veatricular fibrillatioa extensively (16, 20, 26, 27, 28, 
29): by means ef single induction shecks (29), direct 
current (28) and alternating current (27), they obtained 
electrical fibrillation thresholds as an index of the 
susceptibility of the myocardium to VF. 
Despite over 50 years of investigation, the exact 
nature of VP remaias to be defined. 
2. Earlier Methods of Testing Antifi-rillary Ageats 
Most of the literature conceraed with the evaluatiea 
ofAP ageats pertains to normothermia; in hypothensia, few 
appreaches have found common acceptance. 
Before aa antiarrhythmic &rug caa be tested, there 
must be aa arrhythmia on .Oich to test it. Since arrhyth-
mias are not usually encountered in the normothermic dog, 
2. 
experimental arrhythmias have been produced by a variety 
of methods which may involve damage to the myocardium of 
greater or lesser degree, and include procedures such 
as ligation of the coronary vasculature as described 
by Harris (15); various types of stimulation such as 
electrical or mechanical; and pharmacologic induction with 
substances such as Aconitine, as standardized by Piinz-
metal (23), or involving the administration of a combin-
atbn of cyclopropane and epinephrine. 
In hypothermia, the production of arrhythmias is 
easier; a majority of the dogs succumb spontaneously to 
VF during the process of cooling, usually below 2soc. 
One method for evaluating AF agents (11) takes 
advantage of this fact. Dogs are "cooled to terminus", 
i.e. either VP occurs somewhere below 250c, or the heart 
rate slows pr·ogressively until asystole supervenes. It is 
then determined whether a given drug, administered at some 
empirically selected temperature significantly lowers the 
mean temperature at ~ich VF or asystole occur. While 
iWDrmation of this nature is extremely important, 
Angelakos has pointed out (1) that protection against 
spontaneous VP during cooling need not be synonymous 
with protection against VP during surgery in hypothermia. 
O•r experiences with Antergan (vide infra) tend to 
corroborate this view. 
A second method (1), also widely used, appears 
somewhat more reliable for-our purposes. Dogs are 
..... 
cooled to a predetermined temperature, at which time a 
"standard" surgical maneuver is performed on the heart, 
i.e. right ventriculotomy and exploration. The incid-
ence of VP or mean lethal temperature in "control" 
degs is then compared to the results from dogs receiving 
drugs. 
The werk of Wiggers, Wegria, et al has provided aaether 
basis for AP drug testing: this approach was investigated 
by Shumway et al (25), Coviao and Beavers (8), and by us. 
Our (unpublished) data revealed no correlation between 
electrical VP thresholds and the eccurreaee of VP during 
surgery. 
.,.. 
III. EXPERIMENTAL SECTION 
1. Introeuctiea 
A critical examination of past methods makes it 
dear that certain experimental variables have to be 
minimized or avoided if reliable results are to be 
obtained. 
Oae of the most important variables to consider is 
the dog. Dawes, in his extensive review of the aatter of 
experiaental cardiac arrhythmias (12) states that "evea 
in intricate experiments, performed on whole animals, 
aaalysis reveals individual influences which determine 
whether or not disorders of rhythm shall occur." Not 
all aaimals fibrillate without •rug protectioa, heace it 
becemes essential to determine prier to the admiaistration 
of an AF drug, whether the dog would fibrillate without it. 
Investigation of the aatifibrillary activity of 
various drugs ia hypothermia without prior or coa-
commitaat determination of the duration of action in the 
dosages used, leads to inconsistencies. This point 
bears amplification. Using the paper by Covino, 
Wright, and Charleson (11) as a prototype oae finds 
the following: the experimenters report that tae dogs 
were cooled to terminus: i.e. onset of spoataaeous 
VF or asystole. Dilaatia, Prontesyl, aad Darcorene-
treatee dogs were compared with control groups. However, 
Dilaatin was givea to 9 dogs at a rectal temperature of 
2sOc, aaa to 1 dog at 29°C, and Darcoreae was administered 
s. 
to 8 dogs in 2 doses of 5 ag/Kg each, the first dose 
at 25°C and t~e secead dose at 20°c. Ia two other 
experimeats, &rugs were iajectea at 3 different teaper-
atures. In our experieace, tae time required fer a dog 
te ceol from 290 to 25° is approxiaately 20 minutes, 
while from 25 to 19°c it is in the vicinity of 60 to 
75 aiautes. It becomes clear that the drugs being 
compared in this study all bear a different tiae 
relationship to the end-point of spontaaeous VF at a 
mean temperature of 19.6* 2.0 in control series; no real 
iaformation is obtained either as a basis for, or as a 
result of the antifi~rillary activity of the drugs 
beiag tested, for their activity may well have evaaescea 
before tae dogs reached critical temperatures wita 
respect to VP. 
Therefore, it is highly desirable that aay approach 
used should incorporate some means of estimating the 
duration of action of the 4rug being tested. 
Finally, the investigater's bias, conscious or 
unconscious must be accounted for. The value of "bliad" 
experiments is a time-tested countermeasure for minimizing 
ao investigator's propensity, albeit unconscious, fer 
making ene agent appear more effective than another. 
These considerations largely influenced the molding 
of the method presented below. 
2. Methods 
Random mongrel dogs were anesthetized with intra-
peritoneal pentobarbital, 33 mg/Kg. Positive pressure 
respiration with a pump 1 permitting regulation of rate 
aad volume was instituted as soon as depth of anesthesia 
permitted tracheal intubation. Temperatures were measured 
contisuously in degrees Centigrade, with a Speedomax 2 
Recorder. Deep esophageal temperatures were used 
throughout since in our experience this approximates 
heart temperatures within o.s0c. Contiauous visual 
and audio monitoring of the heart action was obtained 
by connecting an escilloseope and audio amplifier to 
the output of the EKG 3 recoraing lead II. 
Dogs were cooled by immersion in a Frigidaire food 
freezer, containing water in specially constructed 
jacket, the water having been previously cooled to 
2oc. 
The animals were removed from the cold water at 2°C 
above the re~uired temperature to allow for the invariable 
downward continuation of temperature after removal from the 
ice water. They were then allowea to stabilize (24 - 2o0c). 
1Respiratiom Pump, Model No. 1063, Harvard Apparatus Co., Inc., 
Dover, Mass. 
2speedomax Type G Recer8er, &eeds and Northrup Co., Phila-
delphia, Pa. (range 50 - 0 C.). 
3sanborn Viso Cardiette, Sanborn Co., Cambridge, Mass. 
The chest was opened via a right thoracotomy, the 
azygous vein was tied off, and the pericarium widely 
incised. L1gatures were passed under the vena cavae to 
permit occlusion during the ventriculotomy. A right 
ventriculotomy (3 em. incision) was performed, and the 
right ventricle thoroughly explored with the index finger. 
The myocardium was then closed with four to five interrupted 
sutures. Emphasis was not on performing the operation with 
an eye to beiag as gentle as possible to avoid VF or to 
minimize the chances of its occurring, but rather to being 
as strenuous as possible without damaging the myocardium. 
This procedure required 5 miautes' ecclusion time, and all 
ventriculotomies in these experiaents were dome with a timed 
occlusion of 5 minutes. If surgery resulted in VF, the heart 
was defibrillated with countershock 4, the right ventricle 
was sutured, and the ligatures released. The heart was 
allowed five minutes to recover, and then the procedure 
was repeated. If the heart fibrillated a second time, 
the dog was considered a ••fibrillator", and as such, 
adequate for drug testing. Further, it had been shown 
that VF was Drought a8out by introducing the finger into 
and exploring the right ventricle (secosd ventriculotomy), 
aDd not merely by the act of incisimg the ventricle. This 
is important, since it was necessary to establish in every 
~eart Defibrillator, The Mark Co., Randol~h, Mass. (capa-
cities: 280 v for 1/20 sec., 220 v for 1/10 sec., 120 v for 
1/4 sec., all being alternating current). 
s. 
case that exploration was an adequate stimulus for VF in 
the heart "unprotected" by a drug. 
The ~ qua B2! of these prelminary steps was to 
obtain two successive VF 1s. Dogs surviving either ventriculot-
omy were cooled further and re-explored. Any animal not 
fibrillating by 1s0c., or requiring more than four initial 
ventriculotomies to establish it as a fiDrillator, was 
discarded as being unsuitable for drug testing. 
The fibrillator, having fibrillated twice, was given 
ten minutes' respite, and then the drug to be tested was 
injected into the right ventricular chamber over a 60 
second period. The drugs were prepared and injected by 
someone other than the surgeon. The surgeon did not know 
at the time of the experiments which drug was being tested, 
if any, since many placebos (puncture of the right ventricle 
and withdrawal of a few cc. of blood) were used. Ten minutes 
after "injection," the great veins were again occluded, and 
the right ventricle re-explored as previously. This was 
repeated at 20, 30, 45, and 60 minutes respectively after 
the injection, in order to determine 
1. Antifibrillary activity. 
2. Duration of adequate protection, 
with VF re-occurring when drug 
effects wore off. 
For the sake of economy, if a given dog had received 
a placebo instead of a drug, and did fibrillate on the first 
exploration after "injection," the surgeon was informed of 
this fact, and left the room while another "injection" was 
~. 
given without any assurance, however, that the second 
injectiGn was not again a placebo. 
Initially, four Qrugs were screened on 3 dogs each 
by this method, these were: quinidine (10 mg/Kg), procaine 
amide 50 mg/Kg, Aabonestyl 50 mg/Kg, and Antergaa 10 mg/Kg. 
The quinidine tests were then amplified to include a total 
of 10 dogs, intermingled with 7 others receiving placebos. 
Subsequently, a confirmatory test was performed on 
twenty dogs, ten receiving quinidine (10 mg/Kg), and ten 
controls, on a blind basis. These dogs were merely 
cooled to 23.5° t 1°c. aa4 a right ventriculotomy perforaed, 
at ten minutes after "injection" during the standard five-
minute occlusiGn, and the outcome of surgery noted. 
3. Results 
The results are given in Tables 1 and 2 (pages ii and iii). 
The first screening series, inv0lving three dogs per drug, 
were made in order to determine which if aRy of the four 
drugs being tested would be effective were it to be tested 
on a large number of dogs. The statistical method involved 
and its advantages, are discussed elsewhere (2). Briefly, 
judgment is based on the calculation of the exact probability 
(using the Bernoulli theorem) that the observed incidence of 
VP after treatment bears a relation to the effectiveness of 
the drug. For this purpose an effective drug is defined as 
one which would produce a high degree of protection (95%) 
when tested on a large number of animals. In the case of 
Antergan and Pronestyl the probability that they might 
be effective during the first half-hour after injection 
was much too small (P<O.OOl) and therefore these drugs 
can be rejected with a high degree of confidence. For 
Ambonestyl the probability was larger but still rejectable 
(P<0.05) in this rather severe test. By contrast, 
quinidine appeared to have a great probability of effective-
ness (P)0.5) in screening tests, and this was supported 
by the second series of experiments. In the latter the 
difference in the cumulative incidence of VF between 
quinidine-treated and control animals up to 30 minutes 
after injection is statistically highly significant 
(P(O.Ol). 
4. Discussion 
The results indicate that quinidine is 100% effective 
in protecting the hypothermic heart from induced VF for 
15 minutes after the injection of 10 mg/Kg. The observation 
that this protection decreases to 90% in 30 minutes, 70% 
after 45 minutes and 50% within an hour, indicates that 
1:h e result is due to quinidine, the effectiveness of which 
diminishes and disappears, leaving the heart still able 
te respond with VP to the exploratory procedure. In 
retrospect, the evidence in favor of this point would 
have been more reliable had all the dogs subjected to 
multiple exploration been re-explored up to 60 minutes 
after injection regardless of the occurrence of VF during 
11. 
any post-injection exploration, to establish the response 
of the myocardium to subsequent exploration after the &rug 
pretectiom had receded, according to our criteria. Also, 
it is conceivable that the allotted 10 minutes was net 
sufficient to allow maximum drug protection in every case. 
Post-fibrillary explorations would again have provided 
data on this point. 
The additional 20 dogs served to clarify another point. 
According to the method of "aultiple exploration," the 
incisien into the myocardium was made in every case, prior 
to drug administration. It was important to determine 
whether a drug shown to protect against subsequent explor-
ations would also deter VF during actual incision of the 
myocar4ium. In the case of quinidine, this was shown to 
be so. 
The most salient aspect of the method of ••mul tiple 
exploratien" is that in effect, each dog serves as its 
own control. While the incidence of VF under similar 
conditions (artificial ventilation throughout) in 
controls has been previously re~rted as 40 to 60% (4), 
a recemt review of such experiments performed in this 
laboratory reveals that in any small series, the incideace 
ef VF in controls may be anywhere in the 30 to 70% range, 
hence unless confirmed fibrillators are used, one is 
faced with the possibility of attaining 70% control 
over induced VP, with placebos. 
1~. 
T~s method also provides a semi-quantitative assess-
aent of the duration of actien of the agent tested, in the 
aosage used. 
Of the four drugs selected fer iaitial screening 
by this approach, quinidiae and Pronestyl were included 
because they were classical drugs in this field; Ambonestyl 
was selected secause of the report by Covino and Hegnauer (10) 
concersing its AF activity; Antergan was included because 
it had oeen shown to be effective in reducing the incidence 
of spontaneous VP in dogs during cooling (3). Our experience 
with Antergan confirms the view of Angelakos (1) that 
protection against spontaaeous VP is not necessarily 
synonymous with protectien agaiast induced (surgical) 
VP, is hypothermia. 
It is hoped that the anti-fibrillary capacity of 
quinidine may find a more effective application in human 
hypothermia, if it is employed with the awareness of its 
relatively short duration of action. 
IV. SUMMARY 
A new method for evaluatiag anti-fibrillary drugs 
fer use in hypothermia is presented. This method 
involves serial surgical exploration of the •pothermic 
myocardium. Iaitially, two explorations were performed 
to determine if that particular myocardium was subject to 
ventricular fibrillation. Subsequently, after a drug had 
been given, serial explorations were repeated in order to 
evaluate any protection conferred on that myocardium by 
the drug being tested, and the duration of the protection 
conferred. 
The method when used to screen four well-known drugs 
in this field (quinidine, Pronestyl, Ambonestyl, and Antergan) 
clearly indicated the superiority of quinidine. 
Whea the original screeniag of quinidine was amplified, 
then checked Dy aaother method, the screening method was 
found to be reliable, as was the antifierillary action of 
quinidine. 
As evidenced by this method, quiaidine is 100% 
effective in protecting against induced (surgical) 
ventricular fibrillation at temperatures in the range 
of 220c * 20c. This protection declines to 90% in 30 
minutes, 70% in 45 minutes, and 50% in 60 minutes after 
injection of 10 mg/Kg. 
14. 
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TABLE 1. Cumulative Incidence of Ventricular Fibrillati• 
From Surgical Manipulations of The Hypothermic 
Heart.* 
First Series: Before Iujec. Minutes after Injec. 
1. 2. 10-15 3o-35 40-45 60-65 
Ambonestyl 3/3 3/3 1/3 1/3 3/3 
Antergan 3/3 3/3 1/3 2/3 3/3 
Pronestyl 3/3 3/3 2/3 2/3 2/3 2/3 
Quinidine 3/3 3/3 0/3 0/3 1/3 2/3 
Second Series: 
Centrols 7/7 7/7 6/7 7/7 
Quiaidine 17 7/7 0/7 1/7 1/7 3/7 
* .Expressed as the ratio - number fibrillated/total. 
11.1 
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Table 2. Iacidence of VF During Surgery at 23.5 ! 1oc. 
Drug No. of Dogs No. Succum1Jing to VF %VF 
-
Quinidine (10 •g/Kg) 10 0 0 
Placebo 10 6 60 
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